TrueBlue Target Price

Where could TBI trade next? Consensus target price: $9.5.

Get informed when a big investor buys or sells

+ Follow

Share Price

$9.85

Average Target Price

$9.50

3.6% downside

1 analysts in the last 4 months

High: $9.5 | Low: $9.5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-05	Robert W. Baird	$9.5	3.6% downside
2026-02-19	Robert W. Baird	$5.5	44.2% downside
2025-11-05	BMO Capital	$6	39.1% downside
2024-08-07	BMO CapitalJeffrey Silber	$12	21.8% upside
2024-05-07	BMO CapitalJeffrey Silber	$13	32% upside
2024-05-07	Robert W. BairdMark Marcon	$13	32% upside

TrueBlue (TBI) FAQ

TrueBlue (TBI) currently reports a target price of $9.5. Use the charts on this page to explore TrueBlue's target price history and peer comparisons.

Analysts' average 12-month price target for TrueBlue is $9.5, about 3.6% downside from the current share price of $9.85. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $9.5, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for TrueBlue, and consider following TBI for alerts when major investors trade the stock.